David Mark Mcclung serves as Executive at SANGAMO THERAPEUTICS, INC, where they oversee executive responsibilities. Since joining the company, David Mark Mcclung has executed 12 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Nov 25, 2023 involved selling 1,925 shares valued at $732.
David Mark Mcclung currently holds 212,471 shares of SANGAMO THERAPEUTICS, INC (SGMO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Mark Mcclung has been a net neutral trader of SGMO stock. They have purchased $0 and sold $0 worth of shares.
David Mark Mcclung's most recent insider trade was on Nov 25, 2023, when they sold 1,925 shares at $0.38 per share.
Get notified when new Form 4 filings are submitted
| $0.77 |
| Discretionary |
| Jun 25, 2023 | SGMO | $13.7K | Payment | 11,528 | $1.19 | Discretionary |
| May 25, 2023 | SGMO | $2.6K | Payment | 1,925 | $1.33 | Discretionary |
| Feb 25, 2023 | SGMO | $25.9K | Payment | 9,745 | $2.66 | Discretionary |
| Feb 24, 2023 | SGMO | $0 | Award | 56,250 | $N/A | Discretionary |
| Jun 25, 2022 | SGMO | $49.7K | Payment | 11,525 | $4.31 | Discretionary |
| Feb 25, 2022 | SGMO | $0 | Award | 59,400 | $N/A | Discretionary |
| Feb 25, 2022 | SGMO | $27.2K | Payment | 4,610 | $5.90 | Discretionary |
| Jun 25, 2021 | SGMO | $138.5K | Payment | 11,525 | $12.02 | Discretionary |
| Feb 25, 2021 | SGMO | $0 | Award | 40,000 | $N/A | Discretionary |
| Jun 25, 2020 | SGMO | $0 | Award | 100,000 | $N/A | Discretionary |